Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma
Saori Tomimura(Nagasaki University), Shinichi Sato(University of Tokyo Hospital), Kazuhiro Komura(Kanazawa University), Kazuhiro Shimizu(Toho University), Minoru Hasegawa(University of Fukui), Yohei Iwata(Fujita Health University), Eiji Muroi(Nagasaki University), Toshihide Hara(Nagasaki University), Motoi Takenaka(Washington University in St. Louis), Fumihide Ogawa(Nagasaki University), Manabu Fujimoto(Osaka Gakuin University)
Cited by 62
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438